Sequoia Heritage — 2024 Investments

1 investments dated 2024 · listed companies and verified rows first · show all

Kardigankardigan.bio inNASDAQ: KARDJan 2024

Kardigan develops targeted cardiovascular treatments through a discovery and translational research platform, with a pipeline of late-stage drug candidates aimed at functional cures for cardiovascular disease.

AI & Machine LearningBiotechHealthtechMedical Devices

Co-investorsARCH Venture Partners Catalio Capital Management, LP Sequoia Capital T. Rowe Price Venrock

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.